Alpine Global Management’s Pear Therapeutics, Inc. Warrant PEARW Stock Holding History

Alpine Global Management’s Portfolio PEARW Stock Details PEARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-159,832	Closed	-$96K	–	803
2021 Q4	$96K	Sell	159,832 -156,834	-50%	-$159K	0.01%	657
2021 Q3	$301K	Buy	316,666 +166,666	+111%	+$174K	0.07%	170
2021 Q2	$222K	Buy	+150,000	New	+$131K	0.03%	216

Other funds holding PEARW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

PSAMP

P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return

AGC

Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return

KCM

Kingstown Capital Management New York $30.4M AUM 3.71% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Alpine Global Management's PEARW Position: Q1 2022 in Review

Alpine Global Management sold out of Pear Therapeutics, Inc. Warrant (PEARW) in Q1 2022, closing a stake of 159,832 shares — an estimated $96K sold.

Alpine Global Management first reported a position in PEARW in Q2 2021 and held it in 3 quarters. The position peaked at $301K in Q3 2021. 40 funds tracked by Wall St. Rank hold PEARW as of Q1 2022.

Alpine Global Management reported no remaining Pear Therapeutics, Inc. Warrant position as of Q1 2022 after selling out during the quarter.
Alpine Global Management sold 159,832 Pear Therapeutics, Inc. Warrant shares in Q1 2022, an estimated $96K.
Alpine Global Management first reported a position in Pear Therapeutics, Inc. Warrant in Q2 2021 and held it in 3 quarters.
Alpine Global Management's Pear Therapeutics, Inc. Warrant position peaked at $301K in Q3 2021.
40 funds tracked by Wall St. Rank held Pear Therapeutics, Inc. Warrant as of Q1 2022.

Based on Alpine Global Management's 13F filing for Q1 2022, filed 13 May 2022.